This bill amends section 766.101 of the Florida Statutes, which pertains to medical review committees and their immunity from liability. The definition of a "medical review committee" is expanded to include additional entities, such as a managing entity as defined in s. 394.9082(2), and clarifies that these committees may include employees, agents, or consultants deemed necessary for peer review, utilization review, or mortality review of treatment services. The bill also revises the language regarding the immunity of committee proceedings from being subject to discovery or introduction as evidence in civil or administrative actions against healthcare providers or managing entities.

Additionally, the bill specifies that individuals attending committee meetings are not required to testify about evidence or matters presented during those meetings in civil actions. However, it maintains that information available from original sources is not immune from discovery simply because it was presented in committee proceedings. The effective date for this act is set for July 1, 2025.